Clinical Trial Update: Immunogenicity and Safety of Havrix™ Co-Administered With a Diphtheria, Tetanus and Pertussis and a Haemophilus b Vaccine in Children Aged 15 Months [Phase 3]

View source ↗

Summary

Phase 3 trial update on the immunogenicity and safety of Havrix co-administered with diphtheria-tetanus-pertussis and Haemophilus b vaccines in 15-month-old chi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A

Drugs mentioned

• Havrix (hepatitis A vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis A | Phase 3 | Status: COMPLETED | Results posted: 2009-07-24